Skip to main content

Table 2 PH Cox regression univariate analyses for the association of gene SPAG5 with endocrine therapy and chemotherapy

From: The prognostic association of SPAG5 gene expression in breast cancer patients with systematic therapy

 

RFS

OS

DMFS

n

HR

P-value

n

HR

P-value

n

HR

P-value

Systemic therapy subtypes

 Endo

849

1.57 (1.2–2.06)

0.001

128

2 (1.05–3.8)

0.03

513

2.36 (1.57–3.54)

< 0.001

 Tamoxifen-only

739

1.57 (1.17–2.12)

0.0027

114

2.13 (1–4.52)

0.044

556

2.23 (1.52–3.26)

< 0.001

 Chemo

274

1.1 (0.74–1.63)

0.64

69

1.54 (0.74–3.2)

0.25

65

1.49 (0.65–3.4)

0.34

 Endo + chemo

171

2.77 (1.37–5.6)

0.0032

34

4.28 (0.48–38.33)

0.16

86

1.96 (0.66–5.86)

0.22

  1. Endo Endocrine therapy, chemo Chemotherapy
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us